Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Acute Myeloid Leukemia
- AML, Adult
- Chronic Lymphocytic Leukemia
- CLL
- CLL, Refractory
- CLL, Relapsed
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04512105
- Collaborators
- United States Department of Defense
- Investigators
- Principal Investigator: Elizabeth Brem, MD Chao Family Comprehensive Cancer Center
Get Well Soon